Compound of 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, and preparation method thereof

US11530230B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11530230-B2
Application numberUS-201716770956-A
CountryUS
Kind codeB2
Filing dateDec 14, 2017
Priority dateDec 13, 2017
Publication dateDec 20, 2022
Grant dateDec 20, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application discloses a 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, an intermediate, a preparation method and uses thereof. The compound of phosphine ligand is a compound having a structure represented by formula I or formula II, or an enantiomer, a raceme, or diastereomer thereof. The phosphine ligand can be prepared via a preparation scheme in which the cheap and easily available 6,6′-dihydroxyl-3,3,3′,3′-tetramethyl-1,1′-spirobiindane is used as a raw material and the compound represented by formula III serves as the key intermediate. The new phosphine ligand developed by the present application can be used in catalytic organic reaction, in particular as a chiral phosphine ligand that is widely used in many asymmetric catalytic reactions including asymmetric hydrogenation and asymmetric allyl alkylation, and thus it has economic practicability and industrial application prospect.

First claim

Opening claim text (preview).

What is claimed is: 1. A 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, being a compound represented by formula I or formula II, or being an enantiomer, a raceme or a diastereomer thereof: wherein R 1 and R 6 are each independently selected from the group consisting of hydrogen, C 1 -C 10 alkyl or perfluoroalkyl, C 3 -C 6 cycloalkyl, and C 1 -C 4 alkoxy or perfluoroalkoxy; R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, halogen, C 1 -C 10 alkyl or perfluoroalkyl, C 3 -C 6 cycloalkyl, and C 1 -C 4 alkoxy or perfluoroalkoxy; and R 7 is selected from the group consisting of C 1 -C 10 alkyl or perfluoroalkyl, C 3 -C 6 cycloalkyl, and C 6 -C 14 aryl. 2. A synthesis method of the compound represented by formula I according to claim 1 , wherein a racemic or optically active compound represented by formula III, as a raw material, reacts with a di-substituted phosphine halide under an effect of an alkali to obtain the compound represented by formula I via a double-substitution reaction in accordance with the following reaction equation: or wherein the compound represented by formula III and a di-substituted phosphine oxyhalide are subjected to a double-substitution reaction under an effect of an alkali to prepare a compound represented by formula 6, which is then subjected to a reduction reaction to prepare the compound represented by formula I, in accordance with the following reaction equation: and wherein X is halogen, and R 1 -R 7 are the same as those defined in claim 1 . 3. A synthesis method of the compound represented by formula II according to claim 1 , wherein a racemic or optically active compound represented by formula III, as a raw material, reacts with di-substituted phosphine halide under an effect of an under alkali to obtain the compound represented by the formula II via a mono-substitution reaction in accordance with the following reaction equation: or wherein the compound represented by formula III and di-substituted phosphine oxyhalide are subjected to a mono-substitution reaction under an effect of an alkali to prepare a compound represented by formula 7, which is then subjected to a reduction reaction to prepare the compound represented by formula II, in accordance with the following reaction equation: and wherein X is halogen, and R 1 -R 7 are the same as those defined in claim 1 .

Assignees

Inventors

Classifications

  • C07F9/5022Primary

    Aromatic phosphines (P-C aromatic linkage) · CPC title

  • Spiro-condensed ring systems · CPC title

  • comprising aliphatic or saturated rings, e.g. Xantphos · CPC title

  • C07F9/5027Primary

    Polyphosphines · CPC title

  • combined with replacement of hydrogen atoms by halogens · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11530230B2 cover?
The present application discloses a 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, an intermediate, a preparation method and uses thereof. The compound of phosphine ligand is a compound having a structure represented by formula I or formula II, or an enantiomer, a raceme, or diastereomer thereof. The phosphine ligand can be prepared via a preparation scheme in which the cheap …
Who is the assignee on this patent?
Univ Zhejiang
What technology area does this patent fall under?
Primary CPC classification C07F9/5022. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).